Single-Capillary Dual Point-of-Care Testing to Support Cardio-Renal Diagnostic Decision-Making in Ambulatory Care

Pokem, Perrin;Khatib, Ali;Belik, Florian;Ortega, Álvaro;Gruson, Damien;et.al.
(2026) Annals of Clinical & Laboratory Science — Vol. 56, n° 3 (2026)

Files

Single-Capillary Dual Point-of-Care Testing to Support Cardio-Renal Diagnostic Decision-Making in Ambulatory Care.pdf
  • Open Access
  • Adobe PDF
  • 3.16 MB

Details

Authors
  • Pokem, PerrinUCLouvain
    Author
  • Khatib, AliUCLouvain
    Author
  • Belik, Florian
    Author
  • Ortega, Álvaro
    Author
  • Labriola, LauraUCLouvain
    Author
  • Devresse, ArnaudUCLouvain
    Author
  • Pouleur, Anne-CatherineUCLouvain
    Author
  • Gruson, DamienUCLouvain
    Author
Show more
Abstract
Objective. Integrated interpretation of renal function and natriuretic peptides is essential in ambulatory cardio-renal care. This study evaluated whether a single-capillary dual point-of-care testing (POCT) strategy combining creatinine/eGFR and NT-proBNP could support real-time, integrated clinical decision-making during a single consultation. Methods. In this exploratory, single-center, real-world study that was designed as a feasibility study focusing on workflow integration and clinical usability, capillary creatinine/eGFR and NT-proBNP were evaluated using a single-fingerstick dual-POCT workflow in two exploratory clinical subgroups recruited according to their respective clinical indications. Analytical agreement was assessed using Passing-Bablok regression (slope, intercept, and 95% confidence intervals) and Bland-Altman analysis. Agreement at guideline-based clinical thresholds (eGFR ≤60 mL/min/1.73m²; NT-proBNP ≥125 ng/L) was evaluated using Cohen's kappa. Workflow feasibility and time-to-result were also documented. Results. Forty-three patients underwent creatinine/eGFR testing, and a separate subgroup of 22 patients underwent NT-proBNP testing, reflecting different clinical indications and real-world recruitment during this exploratory feasibility study. Passing-Bablok regression showed good agreement with slopes close to unity and no significant systematic bias. Bland-Altman analysis demonstrated clinically acceptable limits of agreement. Diagnostic agreement at clinical thresholds was substantial for eGFR (κ= 0.71) and perfect for NT-proBNP (κ=1.00), with no clinically relevant misclassification. Dual biomarker results were available within approximately 15 minutes, enabling same-visit clinical decisions. Conclusions. A single-capillary dual-biomarker POCT workflow enables rapid and reliable cardio-renal assessment within one ambulatory visit. Its primary value lies in integrated, threshold-based clinical interpretation enabled by the simultaneous availability of complementary biomarkers, rather than analytical comparison alone.
Affiliations

Citations

Pokem, P., Khatib, A., Belik, F., Ortega, Á., Kaddouri, I., Draoui, S., Labriola, L., Devresse, A., Pouleur, A.-C., & Gruson, D. (2026). Single-Capillary Dual Point-of-Care Testing to Support Cardio-Renal Diagnostic Decision-Making in Ambulatory Care. Annals of Clinical & Laboratory Science, 56(3). https://hdl.handle.net/2078.5/279392 (Original work published 2026)